Marielle Christina Baldwin, MD, MPH
Assistant Professor, Family Medicine
Biography
Dr. Baldwin is an Assistant Professor of Family Medicine at the Boston University Chobanian and Avedisian School of Medicine and an addiction specialist at Boston Medical Center. Dr. Baldwin completed her family medicine residency and chief residency at the Boston Medical Center (BMC) in 2017 and is board certified in both Family Medicine and Addiction Medicine.
Since joining the BU Department of Family Medicine faculty, Dr. Baldwin has catalyzed a number of clinical programs and quality improvement efforts. She is the Medical Director for the Stimulant Treatment and Recovery Team (START), a clinic that uses evidence-based contingency management techniques to care for patients with stimulant use disorders and manages acute and chronic presenting needs of people who use drugs. She is the Director of the Office-Based Addiction Treatment (OBAT) Program in Family Medicine at BMC, leads the Hepatitis C Program in Family Medicine, and formerly led the Addiction Pathway for the BMC Family Medicine Residency Program at South Boston Community Health Center and at Greater Roslindale Medical & Dental Center. Her clinical and research interests include stimulant use disorders with a focus on cocaine and methamphetamine use, harm reduction for stimulant use, sexualized drug use, and the integration of stimulant care in primary care settings.
Education
- University of Alabama at Birmingham, MD
- Emory University, MPH
- Emory University, BS
Publications
- Published on 11/27/2024
De La Hoz A, Pooja A, Kancharla A, Schechter-Perkins EM, Ruiz-Mercado G, Baldwin M, Nunes D, Taylor JL. Characteristics and Outcomes of Direct-Acting Antiviral Experienced Patients with Hepatitis C Undergoing Retreatment at an Essential Hospital in the United States. Open Forum Infect Dis. 2024 Dec; 11(12):ofae704. PMID: 39703790.
Read at: PubMed - Published on 5/17/2024
Tilhou A, Baldwin M, Alves J. No Time to Wait: Leveraging Primary Care to Treat Stimulant Use Disorder. Am J Prev Med. 2024 Sep; 67(3):464-469. PMID: 38762205.
Read at: PubMed - Published on 12/14/2023
Uebelacker LA, Braun TD, Taylor LE, Saper R, Baldwi M, Abrantes A, Tremont G, Toribio A, Kirshy S, Koch R, Lorin L, Van Noppen D, Anderson B, Roseen EJ, Stein MD. Evaluation of intervention components to maximize yoga practice among people with chronic pain taking opioid agonist therapy: A factorial experiment using the multiphase optimization strategy framework. Contemp Clin Trials. 2024 Feb; 137:107411. PMID: 38103784.
Read at: PubMed - Published on 9/20/2023
Alves J, Rust V, Baldwin M, Puleikis L, Claude A, Brett M, LaBelle CT, Ventura AS. Starting the Discussion: A Call to Enhance Care for People With Stimulant Use Disorder. Subst Abus. 2023 Jul; 44(3):115-120. PMID: 37728086.
Read at: PubMed - Published on 9/20/2023
Peterkin AF, Baldwin M, Demers L, Gergen Barnett K. Evaluating a Video-Based Addiction Curriculum at a Safety Net Academic Medical Center. Subst Abus. 2023 Jul; 44(3):241-248. PMID: 37728099.
Read at: PubMed - Published on 3/23/2022
Gergen Barnett K, Mishuris RG, Williams CT, Bragg A, Semenya AM, Baldwin M, Howard J, Wilson SA, Srinivasan J. Telehealth's Double-Edged Sword: Bridging or Perpetuating Health Inequities? J Gen Intern Med. 2022 Aug; 37(11):2845-2848. PMID: 35352272.
Read at: PubMed - Published on 2/1/2022
Wusu MH, Baldwin M, Semenya AM, Moreno G, Wilson SA. Racial Justice Curricula in Family Medicine Residency Programs: A CERA Survey of Program Directors. Fam Med. 2022 Feb; 54(2):114-122. PMID: 35143683.
Read at: PubMed